Cargando…

Potential Allylpyrocatechol Derivatives as Antibacterial Agent Against Oral Pathogen of S. sanguinis ATCC 10,556 and as Inhibitor of MurA Enzymes: in vitro and in silico Study

BACKGROUND: Streptococcus sanguinis is Gram-positive bacteria that contribute to caries. Many antibacterial agents are resistant against bacteria so that the discovery of new antibacterial agents is a crucial issue. Mechanism of antibacterial agents by disrupting cell wall bacteria is a promising ta...

Descripción completa

Detalles Bibliográficos
Autores principales: Kurnia, Dikdik, Hutabarat, Geofanny Sarah, Windaryanti, Devi, Herlina, Tati, Herdiyati, Yetty, Satari, Mieke Hemiawati
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7396738/
https://www.ncbi.nlm.nih.gov/pubmed/32801638
http://dx.doi.org/10.2147/DDDT.S255269
_version_ 1783565652087275520
author Kurnia, Dikdik
Hutabarat, Geofanny Sarah
Windaryanti, Devi
Herlina, Tati
Herdiyati, Yetty
Satari, Mieke Hemiawati
author_facet Kurnia, Dikdik
Hutabarat, Geofanny Sarah
Windaryanti, Devi
Herlina, Tati
Herdiyati, Yetty
Satari, Mieke Hemiawati
author_sort Kurnia, Dikdik
collection PubMed
description BACKGROUND: Streptococcus sanguinis is Gram-positive bacteria that contribute to caries. Many antibacterial agents are resistant against bacteria so that the discovery of new antibacterial agents is a crucial issue. Mechanism of antibacterial agents by disrupting cell wall bacteria is a promising target to be developed. One of the enzymes contributing to the cell wall is MurA enzyme. MurA is an enzyme catalyzing the first step of peptidoglycan biosynthesis in the cell wall formation. Inhibiting MurA is an effective and efficient way to kill the bacteria. Source of bioactive compounds including the antibacterial agent can be found in natural product such as herbal plant. Piper betle L. was reported to contain active antibacterial compounds. However, there is no more information on the antibacterial activity and molecular mechanism of P. betle’s compound against S. sanguinis. PURPOSE: The study aims to identify antibacterial constituents of P. betle L. and evaluate their activities through two different methods including in vitro and in silico analysis. MATERIALS AND METHODS: The antibacterial agent was purified by bioactivity-guided isolation with combination chromatography methods and the chemical structure was determined by spectroscopic methods. The in vitro antibacterial activity was evaluated by disc diffusion and dilution methods while the in silico study of a compound binds on the MurA was determined using PyRx program. RESULTS: The antibacterial compound identified as allylpyrocatechol showed inhibitory activity against S. sanguinis with an inhibition zone of 11.85 mm at 1%, together with MIC and MBC values of 39.1 and 78.1 μg/mL, respectively. Prediction for molecular inhibition mechanism of allylpyrocatechols against the MurA presented two allylpyrocatechol derivatives showing binding activity of −5.4, stronger than fosfomycin as a reference with the binding activity of −4.6. CONCLUSION: Two allylpyrocatechol derivatives were predicted to have a good potency as a novel natural antibacterial agent against S. sanguinis through blocking MurA activity that causes disruption of bacterial cell wall.
format Online
Article
Text
id pubmed-7396738
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-73967382020-08-13 Potential Allylpyrocatechol Derivatives as Antibacterial Agent Against Oral Pathogen of S. sanguinis ATCC 10,556 and as Inhibitor of MurA Enzymes: in vitro and in silico Study Kurnia, Dikdik Hutabarat, Geofanny Sarah Windaryanti, Devi Herlina, Tati Herdiyati, Yetty Satari, Mieke Hemiawati Drug Des Devel Ther Original Research BACKGROUND: Streptococcus sanguinis is Gram-positive bacteria that contribute to caries. Many antibacterial agents are resistant against bacteria so that the discovery of new antibacterial agents is a crucial issue. Mechanism of antibacterial agents by disrupting cell wall bacteria is a promising target to be developed. One of the enzymes contributing to the cell wall is MurA enzyme. MurA is an enzyme catalyzing the first step of peptidoglycan biosynthesis in the cell wall formation. Inhibiting MurA is an effective and efficient way to kill the bacteria. Source of bioactive compounds including the antibacterial agent can be found in natural product such as herbal plant. Piper betle L. was reported to contain active antibacterial compounds. However, there is no more information on the antibacterial activity and molecular mechanism of P. betle’s compound against S. sanguinis. PURPOSE: The study aims to identify antibacterial constituents of P. betle L. and evaluate their activities through two different methods including in vitro and in silico analysis. MATERIALS AND METHODS: The antibacterial agent was purified by bioactivity-guided isolation with combination chromatography methods and the chemical structure was determined by spectroscopic methods. The in vitro antibacterial activity was evaluated by disc diffusion and dilution methods while the in silico study of a compound binds on the MurA was determined using PyRx program. RESULTS: The antibacterial compound identified as allylpyrocatechol showed inhibitory activity against S. sanguinis with an inhibition zone of 11.85 mm at 1%, together with MIC and MBC values of 39.1 and 78.1 μg/mL, respectively. Prediction for molecular inhibition mechanism of allylpyrocatechols against the MurA presented two allylpyrocatechol derivatives showing binding activity of −5.4, stronger than fosfomycin as a reference with the binding activity of −4.6. CONCLUSION: Two allylpyrocatechol derivatives were predicted to have a good potency as a novel natural antibacterial agent against S. sanguinis through blocking MurA activity that causes disruption of bacterial cell wall. Dove 2020-07-27 /pmc/articles/PMC7396738/ /pubmed/32801638 http://dx.doi.org/10.2147/DDDT.S255269 Text en © 2020 Kurnia et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Kurnia, Dikdik
Hutabarat, Geofanny Sarah
Windaryanti, Devi
Herlina, Tati
Herdiyati, Yetty
Satari, Mieke Hemiawati
Potential Allylpyrocatechol Derivatives as Antibacterial Agent Against Oral Pathogen of S. sanguinis ATCC 10,556 and as Inhibitor of MurA Enzymes: in vitro and in silico Study
title Potential Allylpyrocatechol Derivatives as Antibacterial Agent Against Oral Pathogen of S. sanguinis ATCC 10,556 and as Inhibitor of MurA Enzymes: in vitro and in silico Study
title_full Potential Allylpyrocatechol Derivatives as Antibacterial Agent Against Oral Pathogen of S. sanguinis ATCC 10,556 and as Inhibitor of MurA Enzymes: in vitro and in silico Study
title_fullStr Potential Allylpyrocatechol Derivatives as Antibacterial Agent Against Oral Pathogen of S. sanguinis ATCC 10,556 and as Inhibitor of MurA Enzymes: in vitro and in silico Study
title_full_unstemmed Potential Allylpyrocatechol Derivatives as Antibacterial Agent Against Oral Pathogen of S. sanguinis ATCC 10,556 and as Inhibitor of MurA Enzymes: in vitro and in silico Study
title_short Potential Allylpyrocatechol Derivatives as Antibacterial Agent Against Oral Pathogen of S. sanguinis ATCC 10,556 and as Inhibitor of MurA Enzymes: in vitro and in silico Study
title_sort potential allylpyrocatechol derivatives as antibacterial agent against oral pathogen of s. sanguinis atcc 10,556 and as inhibitor of mura enzymes: in vitro and in silico study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7396738/
https://www.ncbi.nlm.nih.gov/pubmed/32801638
http://dx.doi.org/10.2147/DDDT.S255269
work_keys_str_mv AT kurniadikdik potentialallylpyrocatecholderivativesasantibacterialagentagainstoralpathogenofssanguinisatcc10556andasinhibitorofmuraenzymesinvitroandinsilicostudy
AT hutabaratgeofannysarah potentialallylpyrocatecholderivativesasantibacterialagentagainstoralpathogenofssanguinisatcc10556andasinhibitorofmuraenzymesinvitroandinsilicostudy
AT windaryantidevi potentialallylpyrocatecholderivativesasantibacterialagentagainstoralpathogenofssanguinisatcc10556andasinhibitorofmuraenzymesinvitroandinsilicostudy
AT herlinatati potentialallylpyrocatecholderivativesasantibacterialagentagainstoralpathogenofssanguinisatcc10556andasinhibitorofmuraenzymesinvitroandinsilicostudy
AT herdiyatiyetty potentialallylpyrocatecholderivativesasantibacterialagentagainstoralpathogenofssanguinisatcc10556andasinhibitorofmuraenzymesinvitroandinsilicostudy
AT satarimiekehemiawati potentialallylpyrocatecholderivativesasantibacterialagentagainstoralpathogenofssanguinisatcc10556andasinhibitorofmuraenzymesinvitroandinsilicostudy